TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
2012
Genome-wide association studies in combination with functional analyses identify a genetic variant that explains why anti-tumour necrosis factor therapy, used in several autoimmune diseases, exacerbates multiple sclerosis.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
286
Citations
NaN
KQI